Cellectar Biosciences, Inc. (CLRB)
1.25
+0.10
(+8.70%)
USD |
NASDAQ |
Nov 06, 16:00
1.24
-0.01
(-0.80%)
After-Hours: 20:00
Cellectar Biosciences Price to Book Value : 0.3453 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.3453 |
| November 05, 2026 | 0.3177 |
| November 04, 2026 | 0.3398 |
| November 03, 2026 | 0.3619 |
| November 02, 2026 | 0.337 |
| October 30, 2026 | 0.3329 |
| October 29, 2026 | 0.337 |
| October 28, 2026 | 0.3426 |
| October 27, 2026 | 0.3343 |
| October 26, 2026 | 0.3343 |
| October 23, 2026 | 0.337 |
| October 22, 2026 | 0.3232 |
| October 21, 2026 | 0.3536 |
| October 20, 2026 | 0.3398 |
| October 19, 2026 | 0.3094 |
| October 16, 2026 | 0.3149 |
| October 15, 2026 | 0.3287 |
| October 14, 2026 | 0.326 |
| October 13, 2026 | 0.384 |
| October 12, 2026 | 0.395 |
| October 09, 2026 | 0.4006 |
| October 08, 2026 | 0.3868 |
| October 07, 2026 | 0.4171 |
| October 06, 2026 | 0.4171 |
| October 05, 2026 | 0.4613 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.4917 |
| October 01, 2026 | 0.5166 |
| September 30, 2026 | 0.5083 |
| September 29, 2026 | 0.5028 |
| September 28, 2026 | 0.5055 |
| September 25, 2026 | 0.4973 |
| September 24, 2026 | 0.5732 |
| September 23, 2026 | 0.5774 |
| September 22, 2026 | 0.616 |
| September 21, 2026 | 0.6492 |
| September 18, 2026 | 0.6575 |
| September 17, 2026 | 0.663 |
| September 16, 2026 | 0.6492 |
| September 15, 2026 | 0.6409 |
| September 14, 2026 | 0.6381 |
| September 11, 2026 | 0.6381 |
| September 10, 2026 | 0.6547 |
| September 09, 2026 | 0.6533 |
| September 08, 2026 | 0.6658 |
| September 04, 2026 | 0.6547 |
| September 03, 2026 | 0.6492 |
| September 02, 2026 | 0.6713 |
| September 01, 2026 | 0.6796 |
| August 31, 2026 | 0.6934 |
| August 28, 2026 | 0.6989 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.644 |
| Alnylam Pharmaceuticals, Inc. | 5.793 |
| Anika Therapeutics, Inc. | 1.416 |
| Savara, Inc. | 6.906 |
| Vericel Corp. | 7.257 |
Price to Book Value Related Metrics
| Price | 1.25 |
| Earnings Yield | -364.3% |
| Market Cap | 10.32M |